Position in EVAX
as of Jun 30, 2026
· filed Sep 2, 2026
Position Value
$113,410
+$47,295 QoQ
Shares Held
36,584
+105.8% QoQ
Ownership
0.439%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 20 holders
Holding Since
Dec 2021
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EVAX Over Time
Shares Held
Position Value (USD)
Derivatives in EVAX
reported options exposure · as of Mar 31, 2024CallValue
$18,400
CallShares
1,150
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,149,545,836 across 435 Biotechnology names. EVAX ranks #346 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in EVAX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $113,410 | 36,584 | Shares | Defined | 2026-09-02 | |
| 2026-03-31 | $66,115 | 17,773 | Shares | Defined | 2026-05-15 | |
| 2024-09-30 | $46,105 | 14,825 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $18,400 | 5,750 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $26,051 | 8,141 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $891 | 1,300 | Put | Defined | 2024-02-14 | |
| 2023-12-31 | $29,360 | 42,800 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $16,896 | 24,630 | Shares | Defined | 2024-02-14 | |
| 2023-03-31 | $20,679 | 18,300 | Call | Defined | 2023-05-15 | |
| 2023-03-31 | $1,356 | 1,200 | Put | Defined | 2023-05-15 | |
| 2022-12-31 | $23,075 | 13,000 | Call | Defined | 2023-02-14 | |
| 2022-12-31 | $887 | 500 | Put | Defined | 2023-02-14 | |
| 2022-12-31 | $2,635 | 1,485 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $364,255 | 138,500 | Put | Defined | 2022-11-14 | |
| 2022-09-30 | $840,548 | 319,600 | Call | Defined | 2022-11-14 | |
| 2022-09-30 | $281,170 | 106,909 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $639,552 | 333,100 | Call | Defined | 2022-08-15 | |
| 2022-06-30 | $160,485 | 83,586 | Shares | Defined | 2022-08-15 | |
| 2022-06-30 | $71,616 | 37,300 | Put | Defined | 2022-08-15 | |
| 2022-03-31 | $38,632 | 12,750 | Shares | Defined | 2022-05-16 | |
| 2022-03-31 | $37,875 | 12,500 | Put | Defined | 2022-05-16 | |
| 2022-03-31 | $701,142 | 231,400 | Call | Defined | 2022-05-16 | |
| 2021-12-31 | $61,438 | 13,900 | Put | Defined | 2022-02-14 | |
| 2021-12-31 | $621,452 | 140,600 | Call | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||